These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 731409)

  • 21. Studies on the mechanism of renal transport depression caused by pretreatment with 2,4,5-trichlorophenoxyacetate.
    Koschier FJ; Berndt WO
    J Toxicol Environ Health; 1976 Nov; 2(2):323-34. PubMed ID: 1011291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dose-dependent pharmacokinetic profile of 2,4,5-trichlorophenoxy acetic acid following intravenous administration to rats.
    Sauerhoff MW; Braun WH; Blau GE; Gehring PJ
    Toxicol Appl Pharmacol; 1976 Jun; 36(3):491-501. PubMed ID: 941149
    [No Abstract]   [Full Text] [Related]  

  • 23. Dose-dependent pharmacokinetic profile of silvex following intravenous administration in rats.
    Sauerhoff MW; Braun WH; LeBeau JE
    J Toxicol Environ Health; 1977 Jan; 2(3):605-18. PubMed ID: 846008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between 2,4,5-trichlorophenoxyacetate and the renal organic base transport system.
    Koschier FJ; Berndt WO
    Biochem Pharmacol; 1977 Sep; 26(18):1709-13. PubMed ID: 143289
    [No Abstract]   [Full Text] [Related]  

  • 25. A model for the dose-dependent pharmacokinetics of chlorophenoxy acid herbicides in the rat: the effect of enterohepatic recycling.
    Colburn WA
    J Pharmacokinet Biopharm; 1978 Oct; 6(5):417-26. PubMed ID: 731409
    [No Abstract]   [Full Text] [Related]  

  • 26. The pharmacokinetics of chlorinated phenoxy acid herbicides: a literature review.
    Arnold EK; Beasley VR
    Vet Hum Toxicol; 1989 Apr; 31(2):121-5. PubMed ID: 2648672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silvex (2,4,5-TP).
    Rev Environ Contam Toxicol; 1988; 104():195-202. PubMed ID: 3062697
    [No Abstract]   [Full Text] [Related]  

  • 28. Dose-dependent pharmacokinetics: emphasis on phase I metabolism.
    Dayton PG; Sanders JE
    Drug Metab Rev; 1983; 14(3):347-405. PubMed ID: 6347591
    [No Abstract]   [Full Text] [Related]  

  • 29. Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.
    Roberts MS; Magnusson BM; Burczynski FJ; Weiss M
    Clin Pharmacokinet; 2002; 41(10):751-90. PubMed ID: 12162761
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.